Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Hematopoietic Bone Marrow Transplantation for Patients With High-risk Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), or Myelodysplastic Syndrome (MDS) Using Related HLA-Mismatched Donors: A Trial Using Radiolabeled Anti-CD45 Antibody Combined With Immunosuppression Before and After Transplantation

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00589316
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:39:19.475751+00:00
Published At
2023-02-09T00:00:00+00:00
Record Updated At
2023-02-09
Results Posted At
2023-02-09
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome", "Adult Acute Lymphoblastic Leukemia in Remission", "Adult Acute Myeloid Leukemia in Remission", "CD45-Positive Neoplastic Cells Present", "Chronic Myelomonocytic Leukemia", "Previously Treated Myelodysplastic Syndrome", "Refractory Anemia With Excess Blasts", "Refractory Anemia With Ring Sideroblasts", "Refractory Cytopenia With Multilineage Dysplasia", "Refractory Cytopenia With Multilineage Dysplasia and Ring Sideroblasts"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2023-02-09"
protocolSection.identificationModule.nctId
"NCT00589316"
protocolSection.identificationModule.officialTitle
"Hematopoietic Bone Marrow Transplantation for Patients With High-risk Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), or Myelodysplastic Syndrome (MDS) Using Related HLA-Mismatched Donors: A Trial Using Radiolabeled Anti-CD45 Antibody Combined With Immunosuppression Before and After Transplantation"
protocolSection.statusModule.overallStatus
"TERMINATED"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2023-02-09"

Study condition terms

  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome (protocolSection.conditionsModule.conditions)
  • Adult Acute Lymphoblastic Leukemia in Remission (protocolSection.conditionsModule.conditions)
  • Adult Acute Myeloid Leukemia in Remission (protocolSection.conditionsModule.conditions)
  • CD45-Positive Neoplastic Cells Present (protocolSection.conditionsModule.conditions)
  • Chronic Myelomonocytic Leukemia (protocolSection.conditionsModule.conditions)
  • Previously Treated Myelodysplastic Syndrome (protocolSection.conditionsModule.conditions)
  • Refractory Anemia With Excess Blasts (protocolSection.conditionsModule.conditions)
  • Refractory Anemia With Ring Sideroblasts (protocolSection.conditionsModule.conditions)
  • Refractory Cytopenia With Multilineage Dysplasia (protocolSection.conditionsModule.conditions)
  • Refractory Cytopenia With Multilineage Dysplasia and Ring Sideroblasts (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.